Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients.
about
Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status.Prevention of Invasive Aspergillus Fungal Infections with the Suspension and Delayed-Release Tablet Formulations of Posaconazole in Patients with Haematologic Malignancies.Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with haematological malignancies
P2860
Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Posaconazole plasma exposure c ...... stem cell transplant patients.
@en
Posaconazole plasma exposure c ...... stem cell transplant patients.
@nl
type
label
Posaconazole plasma exposure c ...... stem cell transplant patients.
@en
Posaconazole plasma exposure c ...... stem cell transplant patients.
@nl
prefLabel
Posaconazole plasma exposure c ...... stem cell transplant patients.
@en
Posaconazole plasma exposure c ...... stem cell transplant patients.
@nl
P2093
P2860
P50
P1476
Posaconazole plasma exposure c ...... stem cell transplant patients
@en
P2093
Hélène Schoemans
Isabel Spriet
Johan Maertens
Katrien Lagrou
Kim Vanstraelen
Koen Theunissen
Nele Peersman
P2860
P2888
P304
P356
10.1007/S00228-016-2057-6
P577
2016-04-11T00:00:00Z